MREO — Mereo BioPharma Group plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1719714 ·
United Kingdom
Last close
$0.31
Market Cap
$48.68M
52W High
$0.42
52W Low
$0.22
ADV30
5,320,650
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -8,671,000 | -6,719,000 | 40,614,000 | 36,223,000 | 6,560,000 |
| Dec 2025 | 0 | 0 | -7,917,000 | -7,351,000 | 45,917,000 | 40,992,000 | 5,001,000 |
| Sep 2025 | 0 | 0 | -9,569,000 | -7,024,000 | 53,602,000 | 48,698,000 | 7,004,000 |
| Jun 2025 | 500,000 | 368,000 | -9,754,000 | -14,616,000 | 62,631,000 | 56,125,000 | 8,454,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-26,954,000
Investing CF
$0
Financing CF
$-95,000
CapEx
$-620,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.30
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-507,538,000
Inventory
—
Receivables
$1,879,000
ST Investments
—
EBIT TTM
$-35,615,000
Pretax Income TTM
$-35,710,000
Interest Exp TTM
$95,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$500,000
EBITDA
$-35,577,500
Free Cash Flow
—
Enterprise Value
$12,459,809
Total Cash
$36,223,000
Total Debt
$0
Shares Out
159,618,609
Trailing EPS
$-0.20
Book Value
$0.21
ROE
-75.9%
ROA
-41.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 500,000 | -38,257,000 | -41,878,000 | 45,917,000 | 5,001,000 | — | -30,971,000 |
| Dec 2024 | 0 | -45,715,000 | -43,253,000 | 76,390,000 | 15,421,000 | — | -32,834,000 |
| Dec 2023 | 10,000,000 | -27,136,000 | -29,466,000 | 66,499,000 | 15,962,000 | — | -21,132,000 |
| Dec 2022 | 0 | -52,698,000 | -42,220,000 | 77,413,000 | 26,011,000 | — | -48,821,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.04
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KALA | KALA BIO, Inc. | $48.89M | $2.63 | — |
| ACTU | ACTUATE THERAPEUTICS, INC. | $48.33M | $2.02 | — |
| VERU | VERU INC. | $48.15M | $3.00 | — |
| LTRN | Lantern Pharma Inc. | $49.50M | $3.88 | — |
| INCR | Intercure Ltd. | $47.79M | $0.87 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
2026-06-15 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
2026-06-12 15:14 · Yahoo
European Equities Traded in US as ADRs Rise in Thursday Trading
2026-06-11 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
2026-06-08 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
2026-06-03 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
2026-06-02 15:08 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
2026-06-01 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week
2026-05-29 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
2026-05-26 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
2026-05-22 15:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.